4DMedical (ASX:4DX), a leader in respiratory imaging technology, has appointed Julian Sutton as CFO and executive director.
Sutton, an early investor in the company, has served as a non-executive director since September 2017, bringing extensive experience in technology, strategy, and commercial operations.
During his tenure on the board, Sutton played a key role in capital strategy, corporate governance, and investor relations, helping secure funding to support 4DMedical's product development, regulatory milestones, and commercial expansion.
His promotion to the executive team comes amid a period of strong commercial momentum, including FDA clearance of the company's CT:VQ imaging platform and its deployment at leading US academic medical centers, as well as a new global distribution partnership with Philips.
"Julian has been a trusted adviser to 4DMedical for many years, contributing significantly to our growth and investor engagement," said CEO and Founder Andreas Fouras.
"As the momentum behind CT:VQ continues, formalising Julian’s role on the executive team is a natural step. His deep understanding of the business and capital markets expertise will be invaluable as we scale globally."
At the time of reporting, 4DMedical's share price was $4.60.